174 related articles for article (PubMed ID: 28192156)
1. Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.
Blaich A; Frei R; Castellano C; Kiessling C; Geschke A; Rentsch KM; Egli A
J Microbiol Methods; 2017 Apr; 135():63-65. PubMed ID: 28192156
[TBL] [Abstract][Full Text] [Related]
2. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
[TBL] [Abstract][Full Text] [Related]
4. [Experience with laboratory diagnosis of Clostridium difficile].
Bareková L; Zálabská E; Hanovcová I
Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
Shin BM; Lee EJ; Moon JW; Lee SY
Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
[TBL] [Abstract][Full Text] [Related]
6. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
10. A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays.
Sharp SE; Ivie WM; Buckles MR; Coover DM; Pohl JC; Hatcher PA
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):344-6. PubMed ID: 19376666
[TBL] [Abstract][Full Text] [Related]
11. Glutamate dehydrogenase as confirmatory test for Clostridium difficile toxin A/B-positive stools.
Bignardi GE; Settle C
J Hosp Infect; 2010 Aug; 75(4):327-8. PubMed ID: 20227790
[No Abstract] [Full Text] [Related]
12. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
[TBL] [Abstract][Full Text] [Related]
13. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile.
Reller ME; Lema CA; Perl TM; Cai M; Ross TL; Speck KA; Carroll KC
J Clin Microbiol; 2007 Nov; 45(11):3601-5. PubMed ID: 17804652
[TBL] [Abstract][Full Text] [Related]
14. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
[TBL] [Abstract][Full Text] [Related]
16. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
Chang FC; Liu CP; Sun FJ; Lin CC
J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of Clostridium difficile infections: comparative study of two immuno enzyme assays with confirmation by PCR and culture followed by PCR ribotyping].
Krůtová M; Matějková J; Zajac M; Hubáček P; Nyč O
Epidemiol Mikrobiol Imunol; 2014 Jun; 63(2):99-102. PubMed ID: 25025672
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile testing algorithms: what is practical and feasible?
Schmidt ML; Gilligan PH
Anaerobe; 2009 Dec; 15(6):270-3. PubMed ID: 19853666
[TBL] [Abstract][Full Text] [Related]
19. Comparison of GeneXpert PCR to BD GeneOhm for detecting C. difficile toxin gene in GDH positive toxin negative samples.
Agaronov M; Karak SG; Maldonado Y; Tetreault J; Aslanzadeh J
Ann Clin Lab Sci; 2012; 42(4):397-400. PubMed ID: 23090736
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.
Ylisiurua P; Koskela M; Vainio O; Tuokko H
Scand J Infect Dis; 2013 Jan; 45(1):19-25. PubMed ID: 22998479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
